New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;HMY;MRK;BAC From The Last 14 Days
Check below for free stories on AAPL;HMY;MRK;BAC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>
September 16, 2014
07:31 EDTMRKEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
07:25 EDTMRKMerck price target raised to $72 from $62 at SunTrust
After meeting with Merck's CEO and head of clinical development, SunTrust increased its price target on the company as the firm thinks that it is ideally positioned across five of the fastest growing therapeutic classes. The firm believes that the company's EPS growth rates from 2015-2020 will be three percentage points above Street estimates, while it has a first-mover advantage in oncology. It keeps a Buy rating on the shares.
07:19 EDTAAPLCompanies' share buybacks at fasttest clip since 2007, WSJ reports
Companies are buying back their own shares at its fastest pace since the financial crisis to fuel a stock rally, reports the Wall Street Journal. According to Birinyi Associates, companies have bought back $338.3B of stock in 1H14, the most since 2007. Citing an analysis by Barclays, companies with the largest buyback programs by dollar value have outperformed the broader market by 20% since 2008. Reference Link
06:42 EDTAAPLPayPal running ads against Apple Pay, Business Insider reports
Subscribe for More Information
06:36 EDTAAPLiPhone 6/6 Plus may suffer similar iPhone 5s/5c inventory issues, DigiTimes says
Subscribe for More Information
06:28 EDTAAPLLenovo, Huawei look to pose threat in high-end smartphone segment, DigiTimes says
Subscribe for More Information
06:03 EDTBACHuntington Bancshares completes acquisition of 24 Bank of America branches
Subscribe for More Information
September 15, 2014
17:24 EDTBACBank of America releases results of its mid-cycle stress test
In a severely adverse scenario, Bank of America's total capital ratio would be 10.7% through 2Q16. The company's common equity tier 1 capital ratio would be 8.2% through 2Q16.
17:09 EDTAAPLOn The Fly: Closing Wrap
Stocks on Wall Street were mixed to begin the week, as the Dow managed to register mild gains but the Nasdaq was weighed down by slides in a number of so-called "momentum stocks" like Tesla (TSLA). Investors may remain cautious in the next two sessions ahead of the Fed's much anticipated rate decision and accompanying statement, which is due Wednesday. ECONOMIC EVENTS: In the U.S., New York Fed's Empire state survey for September rose to a five-year high of 27.54. Industrial production unexpectedly dipped 0.1% in August from a downwardly revised 0.2% July gain, missing the forecast for a rise of 0.3%. Capacity utilization dropped to 78.8% last month from 79.1% previously. In China, industrial output increased 6.9% in August versus the same period a year earlier, which was its weakest advance, excluding months that fell during New Year holidays, since December 2008. Chinese retail sales growth for August came in at 11.9%, missing the consensus estimate. COMPANY NEWS: Shares of Apple (AAPL) edged down 3c, or 0.03%, to $101.63 despite the company's announcement that a record 4M iPhone 6 and iPhone 6 Plus pre-orders were placed in the first 24 hours that ordering was available. Demand for the new phones exceeds the initial pre-order supply, the company added, stating that delivery of "many" iPhone pre-orders have been pushed out to October... Microsoft (MSFT) slid 45c, or 0.97%, to $46.24 after the company confirmed an agreement to acquire Mojang, the developer for the "Minecraft" video game franchise, for $2.5B... MAJOR MOVERS: Among the notable gainers was Avanir Pharmaceuticals (AVNR), which surged $5.75, or 85.31%, to $12.49 and was upgraded to Buy from Hold at Jefferies after the company announced results from its phase II clinical trial evaluating the safety and efficacy of its treatment of agitation in patients with Alzheimer's disease. Also higher was SABMiller (SBMRY), which jumped $4.72, or 8.5%, to $60.26 after the Wall Street Journal said that ABInBev (BUD) was looking to obtain financing for an acquisition of the U.K.-based brewer and Heineken (HEINY) confirmed that it rebuffed SABMiller's approach regarding a potential transaction. The news of potential consolidation in the space also drove other beer makers highers, with Molson Coors (TAP) rising $4.20, or 5.85%, to $76.00 and Boston Beer (SAM) gaining 71c, or 0.33%, to $218.47. Among the noteworthy losers was Tesla (TSLA), which dropped $25.34, or 9.08%, to $253.86 after Morgan Stanley analyst Adam Jones wrote that he agrees with the assertion of Tesla's CEO Elon Musk that the company's stock may have gotten ahead of itself. Also lower were shares of NPS Pharmaceuticals (NPSP), which fell $5.42, or 16.56%, to $27.28 after Oppennheimer and Jefferies stated that approval of its Natpara drug for hypoparathyroidism could be delayed after concerns were raised during an FDA panel meeting, even though the advisors were in favor of approving the drug. INDEXES: The Dow rose 43.63, or 0.26%, to 17,031.14, the Nasdaq dropped 48.70, or 1.07%, to 4,518.90, and the S&P 500 declined 1.41, or 0.07%, to 1,984.13.
16:00 EDTAAPLOptions Update; September 15, 2014
iPath S&P 500 VIX Short-Term Futures up 73c to 29.34 Option volume leaders: AAPL TSLA NFLX BAC TWTR AMZN BP NFLX YHOO FB VLO according to Track Data.
13:30 EDTMRKMerck announces data from pivotal Phase 3 study for odanacatib
Merck announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis. Odanacatib is Merck’s investigational once-weekly cathepsin K inhibitor. In the Long-Term Odanacatib Fracture Trial, odanacatib met its primary endpoints and significantly reduced the risk of osteoporotic hip, spine and non-vertebral fractures compared with placebo. The rates of adverse events overall in LOFT were generally balanced between patients taking odanacatib and placebo. Adjudicated events of morphea-like skin lesions and atypical femoral fractures occurred more often in the odanacatib group than in the placebo group. Adjudicated major adverse cardiovascular events were generally balanced overall between the treatment groups. There were numerically more adjudicated stroke events with odanacatib than with placebo.
12:23 EDTAAPLApple iPhone 6 pre-orders imply slight upside to consensus, says Piper Jaffray
Subscribe for More Information
11:09 EDTAAPLRadioShack rises after CFO resigns, analyst suggests Amazon should buy stores
Subscribe for More Information
10:48 EDTBACBank of America reports August default rate 3.33% vs. 3.01% last month
Subscribe for More Information
10:04 EDTAAPLAT&T to particularly benefit from strong Apple iPhone 6 demand, says Wells Fargo
Subscribe for More Information
09:35 EDTAAPL, BACActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA RSH YHOO GILD TWTR AVNR NFLX BAC C
08:32 EDTAAPLMacy's, Bloomingdales to launch same-day delivery in fall 2014
Macy’s (M) outlined its latest advancements in omnichannel strategy and technology as the company continues to add new dimensions for attracting shoppers and serving the needs of individual customers. Macy’s and Bloomingdale’s will help launch Apple (AAPL) Pay, same-day delivery to be piloted in fall 2014, new POS technology and customer service enhancements in testing, new apps, web functionality and mobile wallet launched, and its RFID is being expanded to fashion categories.
08:32 EDTAAPLApple says pre-orders for iPhone 6, iPhone 6 Plus topped 4M in first 24 hours
Subscribe for More Information
08:31 EDTAAPLApple says pre-orders for iPhone 6, iPhone 6 Plus topped 4M in first 24 hours
Subscribe for More Information
08:09 EDTAAPLUSA Technologies can benefit as Apple Pay drives interest, says H.C. Wainwright
H.C. Wainwright expects Apple's (AAPL) payment entry to validate the mobile wallet concept, which can shift the balance in the industry and benefit USA Technologies (USAT). The firm noted that USA Tech provides the backbone of the operation behind Softcard, the mobile wallet joint venture owned by AT&T (T), Verizon (VZ), and T-Mobile (TMUS), and the firm believes that this system may "somehow" be absorbed into Apple Pay (AAPL) in the future. H.C. Wainwright reiterates its Buy rating on USA Technologies.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use